etoposide has been researched along with Autoimmune Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Don, AS; Martinez-Lamenca, C; Proia, RL; Roberts, E; Rosen, H; Webb, WR | 1 |
| He, L; Hua, Z; Liu, M; Wang, Y; Wang, Z; Yao, S; Zhang, R; Zou, H | 1 |
| Aslani, F; Bergmann, M; Bhushan, S; Elsässer, HP; Fijak, M; Fröhlich, S; Keidel, M; Klug, J; Mahavadi, P; Meinhardt, A; Schuppe, HC; Sebastian, T | 1 |
| Gottlieb, AB; Seidler, AM | 1 |
| Batár, P; Kiss, A; Kovácsné Kovács, E; Rejto, L; Reményi, G; Sípos, T; Szarvas, M; Szász, R; Udvardy, M; Váróczy, L | 1 |
| Kallio, M; Lähdetie, J | 1 |
| Capria, S; Mandelli, F; Meloni, G; Modena, V; Vignetti, M | 1 |
1 review(s) available for etoposide and Autoimmune Diseases
| Article | Year |
|---|---|
Dermatomyositis induced by drug therapy: a review of case reports.
Topics: Adult; Aged; Antibodies, Antinuclear; Autoimmune Diseases; Cyclophosphamide; Dermatomyositis; Etoposide; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin | 2008 |
6 other study(ies) available for etoposide and Autoimmune Diseases
| Article | Year |
|---|---|
Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues.
Topics: Animals; Apoptosis; Autoimmune Diseases; bcl-2-Associated X Protein; Calcium Signaling; Caspases; Cell Membrane Permeability; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Fingolimod Hydrochloride; HeLa Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lymphoproliferative Disorders; Mice; Mice, Knockout; Mitochondria; Mutagenesis; Organ Specificity; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Protein Transport; Receptors, Lysosphingolipid; Sphingolipids; Sphingosine; Spleen; Thymus Gland | 2007 |
Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen.
Topics: Adult; Autoimmune Diseases; Chemokine CXCL10; Chemokine CXCL12; Etoposide; Glucocorticoids; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-10; Interleukin-18; Interleukin-7; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Retrospective Studies; Tumor Necrosis Factor-alpha | 2022 |
Resistance to apoptosis and autophagy leads to enhanced survival in Sertoli cells.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autoimmune Diseases; Autophagy; Caspase 3; Cell Survival; Cisplatin; Cross-Sectional Studies; Cytochromes c; Disease Models, Animal; Etoposide; Fatty Alcohols; Gene Expression Regulation, Developmental; Humans; Infertility, Male; Male; Membrane Potential, Mitochondrial; Orchitis; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Sertoli Cells; Spermatogenesis; Staurosporine | 2017 |
[One hundred fifty autologous peripheral haemopoietic stem cell transplantations and their lessons].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hungary; International Cooperation; Kaplan-Meier Estimate; Leiomyosarcoma; Lymphoma, Non-Hodgkin; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2009 |
Analysis of micronuclei induced in mouse early spermatids by mitomycin C, vinblastine sulfate or etoposide using fluorescence in situ hybridization.
Topics: Animals; Autoimmune Diseases; Centromere; CREST Syndrome; DNA Probes; Etoposide; Fluorescent Antibody Technique; In Situ Hybridization, Fluorescence; Male; Mice; Micronucleus Tests; Mitomycin; Spermatids; Spindle Apparatus; Topoisomerase II Inhibitors; Vinblastine | 1993 |
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Idarubicin; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine | 1997 |